Matthew Abbott
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew Abbott
Matthew Abbott is recorded as CFO at Chemours Co (CC). Chemours Co reported in an 8-K filed February 29, 2024 that Matthew Abbott was appointed Interim Chief Financial Officer, effective February 28, 2024. Chemours Co reported in an 8-K filed June 6, 2023 that Matthew Abbott was appointed Senior Vice President, Chief Enterprise Transformation Officer, effective June 6, 2023.
“On February 28, 2024, the Board of Directors of The Chemours Company ("Chemours" or the "Company") appointed Denise Dignam as the Interim Chief Executive Officer and Matthew Abbott as the Interim Chief Financial Officer (principal financial and accounting officer).”
“Additionally, Matthew Abbott, Vice President, Digital and Data Analytics Leader, is appointed Senior Vice President, Chief Enterprise Transformation Officer, effective June 6, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Chemours Co (CC)
SEC 8-K
Current2023-06-06–present
-
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Chemours Co
Other people whose current roles at this company are on record from its filings.
- Mark E. Newman CEO, Board Member
- Mark Vergnano CEO, Chairman
- Jonathan Lock CFO
- Mark Newman COO
- Kristine Wellman General Counsel
- Camela T. Wisel Chief Accounting Officer
- David A. Will Chief Accounting Officer
- Shane Hostetter Chief Accounting Officer
- Alister Cowan Board Member
- Alister Cowan BA, CA Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.